← Back to Search

Behavioral Intervention

HOP Program for Mental Illness

N/A

Recruiting

Led By Nicolas Rüsch, Dr.

Research Sponsored by University of Ulm

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least a moderate level of self-reported disclosure-related distress/difficulty (score 4 or higher on the screening item 'In general, how distressed or worried are you in terms of secrecy or disclosure of your mental illness to others?', rated from 1, not at all, to 7, very much)

Age 18 or above

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3, 6 and 12 weeks (t3)

Awards & highlights

Study Summary

This trial will test a new group intervention for soldiers with mental illness to see if it is effective.

Who is the study for?

This trial is for soldiers and first responders in Berlin, Germany who are fluent in German, aged 18 or above, currently receiving mental health treatment, and experiencing distress about disclosing their mental illness. They must have a diagnosed mental disorder but not solely substance-related disorders.Check my eligibility

What is being tested?

The 'Honest, Open, Proud' program is being tested to see if it helps soldiers with mental illnesses feel better about discussing their condition. It's a group-based intervention designed to reduce the discomfort associated with talking about one's own mental health issues.See study design

What are the potential side effects?

Since 'Honest, Open, Proud' is a psychological support program rather than a medication or medical procedure, traditional side effects are not applicable. However, participants may experience emotional discomfort or increased anxiety when confronting issues related to their illness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I feel moderately to very distressed about sharing my mental illness with others.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3, 6 and 12 weeks (t3)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3, 6 and 12 weeks (t3)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6 and 12 weeks (t3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Stigma Stress Scale, 8 items

WHOQoL BREF; Domain psychological quality of life, 6 items

Secondary outcome measures

Attitudes to disclosure, 2 items

Attitudes to help-seeking, 2 items

Disclosure related distress ("In general, how distressed or worried are you in terms of secrecy or disclosure of your mental illness to others?', from 1, not at all, to 7, very much)

+8 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Honest, Open, ProudExperimental Treatment1 Intervention

The group program is about disclosure versus secrecy of one's mental illness. The groups are facilitated by two peers (soldiers with lived experience of mental illness). Each group runs for three weeks, one meeting per week, and two hours per meeting. There is one 2-hour booster session in week 6. Fidelity to manual: rated by a research assistant who is present during the group session

Group II: Control groupActive Control1 Intervention

Treatment as usual (TAU)

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of UlmLead Sponsor

182 Previous Clinical Trials

66,715 Total Patients Enrolled

1 Trials studying Mental Health Disorders

1,000 Patients Enrolled for Mental Health Disorders

Center for Military Mental Health, Berlin, GermanyUNKNOWN

Illinois Institute of Technology, Chicago, USAUNKNOWN

1 Previous Clinical Trials

100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any opportunities to enrol in this experiment?

"This medical trial, which was first listed on November 15th 2017, is not currently recruiting. Its latest update was posted on December 1st 2020 and it has since been discontinued; however, 385 other studies are actively enrolling patients right now."

Answered by AI

What is the focus of this clinical trial's aims?

"This clinical trial has been devised to measure the World Health Organisation Quality of Life BREF Domain psychological quality of life, with 6 items assessed over a 3 week period. Secondary endpoints involve Ryff's 1989 Psychological Well-Being Scale (18 items), Boyd et al.'s 2014 Internalized Stigma of Mental Illness Inventory Brief Version (10 items) and Link et al.'s 1991 Secrecy and Social Withdrawal subscales from the Stigma Coping Orientation Scales (12 items)."

Answered by AI

Recent research and studies

Psychological MedicineJournal

Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment

THE WHOQOL GROUP. 1998. “Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment”. Psychological Medicine. Cambridge University Press (CUP). doi:10.1017/s0033291798006667.

Journal of General Internal MedicineJournal

The PHQ-9

Kroenke, Kurt, Robert L. Spitzer, and Janet B. W. Williams. 2001. “The PHQ-9”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1046/j.1525-1497.2001.016009606.x.

clinicaltrials.govStudy

Honest, Open, Proud for Soldiers With Mental Illness

Nicolas Rüsch 2017. "Honest, Open, Proud for Soldiers With Mental Illness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03218748.

All > Mental Illness